Validation of the Antineutrophil Cytoplasmic Antibody Renal Risk Score and Modification of the Score in a Chinese Cohort With a Majority of Myeloperoxidase-Positive Patients.
- DOI
- 10.3899/jrheum.220818
- Published
- 2023 May
- Container
- The Journal of rheumatology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3899/jrheum.220818,
title = {Validation of the Antineutrophil Cytoplasmic Antibody Renal Risk Score and Modification of the Score in a Chinese Cohort With a Majority of Myeloperoxidase-Positive Patients.},
author = {Ni A and Chen L and Lan L and Wang Y and Ren P and Zhu Y and Xu Y and Shen X and Zhou Q and Huang X and Wang H and Chen J and Han F},
year = {2023},
journal = {The Journal of rheumatology},
doi = {10.3899/jrheum.220818},
url = {https://doi.org/10.3899/jrheum.220818}
}RIS
TY - JOUR TI - Validation of the Antineutrophil Cytoplasmic Antibody Renal Risk Score and Modification of the Score in a Chinese Cohort With a Majority of Myeloperoxidase-Positive Patients. AU - Ni A AU - Chen L AU - Lan L AU - Wang Y AU - Ren P AU - Zhu Y AU - Xu Y AU - Shen X AU - Zhou Q AU - Huang X AU - Wang H AU - Chen J AU - Han F PY - 2023 JO - The Journal of rheumatology DO - 10.3899/jrheum.220818 UR - https://doi.org/10.3899/jrheum.220818 ER -
APA
A, N., L, C., L, L., Y, W., P, R., Y, Z., Y, X., X, S., Q, Z., X, H., H, W., J, C., & F, H. (2023). Validation of the Antineutrophil Cytoplasmic Antibody Renal Risk Score and Modification of the Score in a Chinese Cohort With a Majority of Myeloperoxidase-Positive Patients.. The Journal of rheumatology. https://doi.org/10.3899/jrheum.220818
Source records
- pubmed · retrieved 2026-09-25T19:58:23.360Z